Mutated BCL6 proteins block a signal that should normally bring cancerous cells to activate apoptosis. Traditional, non-destructive cancer treatments have been targeting oncogenes to try and shut the cancer down, while the new study proposes a mechanism to exploit them instead. "You take something that the cancer is addicted to for its survival and you flip the script and make that be the very thing that kills it," Crabtree said.